Cognition Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cognition Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cognition Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cognition Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $89k | 66k | 1.35 |
| 2025-06-30 | $3.5k | 11k | 0.31 |
| 2025-03-31 | $0 | 1 | 0.00 |
| 2024-12-31 | $41k | 41k | 1.00 |
| 2024-09-30 | $93k | 198k | 0.47 |
| 2023-06-30 | $1.1k | 610 | 1.83 |
| 2022-12-31 | $12k | 5.5k | 2.10 |
| 2022-09-30 | $6.0k | 3.2k | 1.88 |
| 2022-06-30 | $2.0k | 899 | 2.22 |
| 2022-03-31 | $10k | 3.7k | 2.67 |
| 2021-12-31 | $24k | 3.7k | 6.40 |